Novo Nordisk Pharmatech A/S: Financial statements 2017
CVR: 13246149
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Novo Nordisk Pharmatech A/S (CVR 13246149) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 622,436,000 and a net result of DKK 103,665,000 compared with DKK 87,367,000 the year before. That is a decrease of 7% compared with the year before. The profit margin was 16.7%. Equity in the 2017 report amounted to DKK 528,953,000. The solvency ratio was 78.2%. The company had 163 employees in the financial year.
- Revenue
- DKK 622,436,000
- Gross Profit
- DKK 263,449,000
- Profit/Loss
- DKK 103,665,000
- Equity
- DKK 528,953,000
- Total Assets
- DKK 676,372,000
- Employees
- 163
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 622.4M | 263.4M | 103.7M | 529M | 163 |
| 2016 | 669.1M | 238M | 87.4M | 468.3M | 158 |
| 2015 | 505.2M | 228M | 92.1M | 400.9M | 150 |
| 2014 | 495.2M | 176.6M | 55.3M | 336.8M | 150 |
| 2013 | 498M | 170.7M | 46.7M | 304.5M | 141 |
Official annual report
Keep an eye on Novo Nordisk Pharmatech A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Novo Nordisk Pharmatech A/S has published its annual report for 2016. Revenue came to DKK 669,077,000, and the net result was DKK 87,367,000.
As of January 27, 2017, Claus Steensen Sølje has joined the board of directors of Novo Nordisk Pharmatech A/S.
About Novo Nordisk Pharmatech A/S
Novo Nordisk Pharmatech A/S is a Danish company of the type Aktieselskab based in Køge, founded in 1989. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named FEF CHEMICALS A/S and FERROSAN FINE CHEMICALS A/S. The management consists of Ulla Grove Krogsgaard Thomsen. The board consists of Mette Sofie Mørck Jarl (chair), Christian Brøgger Stolberg, Jacob Sten Petersen and Joachim Juel Hagemeister. The company is owned by NOVO NORDISK A/S. The company has 489 employees (2026). In 2025, the company reported revenue of DKK 1,041,584,000 and a net result of DKK 113,891,000 compared with DKK 60,619,000 the year before. Equity in the 2025 report amounted to DKK 2,441,318,000.
